InsiderInsights.com Daily Round Up 8/18/16: L.B. Foster, Compass Diversified, Cavium
Dollar value is only one metric to assess the significance of an insider transaction, but when high dollar value intersects with significance it spotlights a stock investors should take the time to consider. InsiderInsights Daily Round Up articles are intended as initial research tools, so investors can separate real insider investment intelligence from time-wasting noise.
Click the Company Name links in the tables below to analyze a company’s or insider’s full insider history.
Educational note from InsiderInsights:
Insider filing volumes are increasing, and will stay high through mid-September. That means the all-to-common insignificant high-dollar trades push all the significant lower-dollar transactions off our Round Up tables.
On Today’s Tables:
Insider trades were rated Significant at:
- Foster L B (NASDAQ:FSTR);
- Compass Diversified (NYSE:CODI), and;
- Cavium (NASDAQ:CAVM).
Insider trades were rated Nearly Significant at:
- Reata Pharm (Pending:RETA), and;
- Guaranty Fed Banc (NASDAQ:GFED).
Insider trades were considered Insignificant at:
- World Wrestling Entertainmentinc (NYSE:WWE);
- Vonage (NYSE:VG);
- Bmc Stock (STCK);
- Spark Therapeutics (NASDAQ:ONCE);
- Alphabet (NASDAQ:GOOG) (NASDAQ:GOOGL);
- Credit Acceptance (NASDAQ:CACC);
- Brixmor Property (NYSE:BRX);
- Activision Blizzard (NASDAQ:ATVI);
- American Financial (NYSE:AFG), and;
- Apple (NASDAQ:AAPL).
There is a Conflicted Insider Signal (both purchases & sales) at:
- Texas Roadhouse (NASDAQ:TXRH), and;
- 21st Century Fox (NASDAQ:FOX).
There is an IPO or Known Corporate Action at:
- Protagonist Therapeutics (Pending:PTGX), and;
- Medpace (Pending:MEDP).
It’s difficult to argue significance for most transactions made during IPOs, or when insiders make trades during a known corporate action.
Insider Purchases
| #: | Filer Name | Insider Titles | Company Name | Ticker | Trans Type |
Dollar Value |
| 1 | Ubben Jeffrey W | DIR | 21st Century Fox | FOX | B | $78,182,496 |
| 2 | Blackstone | BO | Brixmor Property | BRX | B | $12,082,968 |
| 3 | Johnson & Johnson | BO | Protagonist Therapeutics | PTGX | JB* | $6,999,996 |
| 4 | Cpmg | DIR,BO | Reata Pharm | RETA | B | $5,265,419 |
| 5 | Castle Creek Capital V | BO | Guaranty Fed Banc | GFED | B | $1,218,750 |
| 6 | Hussain Muhammad Raghib | COO | Cavium | CAVM | B | $1,037,100 |
| 7 | Nolan Peter J | DIR | Activision Blizzard | ATVI | B | $795,842 |
| 8 | Vizi Bradley | DIR,BO | Foster L B | FSTR | B | $636,086 |
| 9 | Burwig Susan E | VP,OO | Medpace | MEDP | B | $561,082 |
| 10 | Offenberg Alan B | O | Compass Diversified | CODI | B | $512,964 |
Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes :
B =Open-market Buy; AB=10b5-1 (automatic) Buy; JB*=Buy indicated as being open-market, but not confirmed by trading price range and volume for the session.
Insider Sales
| #: | Filer Name | Insider Titles | Company Name | Ticker | Trans Type |
Dollar Value |
| 1 | Blackstone Real Estate Vii | BO | Brixmor Property | BRX | S,JS* | $1,157,520,016 |
| 2 | Children S Hospital Of Philadelphia Foundation | DIR,BO | Spark Therapeutics | ONCE | S | $60,900,000 |
| 3 | Page Lawrence | CEO,DIR,BO | Alphabet | GOOG | AS | $52,679,822 |
| 4 | Gores Group | BO | Bmc Stock | STCK | JS*,S | $39,599,998 |
| 5 | McMahon Vincent K | CEO,DIR,BO | World Wrestling Entertainmentinc | WWE | JS* | $29,895,228 |
| 6 | Federighi Craig | VP | Apple | AAPL | S | $9,840,200 |
| 7 | Watson Jill Foss | BO | Credit Acceptance | CACC | S | $8,553,842 |
| 8 | Lindner Carl H Iii | CEO,PR,DIR | American Financial | AFG | S | $7,383,853 |
| 9 | Taylor Wayne K | CB,CEO | Texas Roadhouse | TXRH | S | $6,904,962 |
| 10 | Citron Jeffrey A | DIR,BO | Vonage | VG | AS | $6,078,256 |
InsiderInsights.com | Key to Insider Title and Trans Type Codes :
S =Open-market Sale; AS=10b5-1 (automatic) Sale; JS*=Sale indicated as being open-market, but not confirmed by trading price range and volume for the session.
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Unique Finance). I have no business relationship with any company whose stock is mentioned in this article.
Editor’s Note: This article covers one or more stocks trading at less than $1 per share and/or with less than a $100 million market cap. Please be aware of the risks associated with these stocks.
